Each year, about 18,000 children and adolescents are diagnosed with type 1 diabetes in the United States. And that number is increasing at a rate of 2.9% each year. Those statistics mean more and more ...

More than 9.5 million people globally live with type 1 diabetes, and this figure is increasing rapidly everywhere, across all age groups. The burden of this autoimmune disease—the risks of which ...

New global data show a dramatic surge in childhood and adolescent diabetes, especially type 2, yet improved care is helping reduce mortality worldwide. Study: Analysis of the global burden of diabetes ...

Tzield, a monoclonal antibody approved for stage 2 Type 1 diabetes, now seeks approval for stage 3 disease based on trial ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is spearheading a pivotal Phase 3 ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Children and adults had an improvement in time in range ...

Diabetes Alliance urges public access to glucose monitors for children with Type 1 diabetes, citing serious health risks, ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 ...

Tirzepatide produced significant weight loss, reduced insulin requirements, and improved glucose control without increasing hypoglycemia when used off-label in adults with type 1 diabetes (T1D), new ...